Healthcare provider profile · identity verified

William Henry Young, MD

Internal Medicine · RICHMOND, VA · NPI 1447368089

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	691	190
Atorvastatin Calcium	Atorvastatin Calcium	391	118
Pravastatin Sodium	Pravastatin Sodium	291	71
Metformin Hcl	Metformin Hcl	290	90
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	222	70
Hydrochlorothiazide	Hydrochlorothiazide	198	61
Losartan Potassium	Losartan Potassium	183	51
Metoprolol Succinate	Metoprolol Succinate	182	51
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	177	55
Albuterol Sulfate Hfa	Albuterol Sulfate	160	55
Omeprazole	Omeprazole	151	47
Potassium Chloride	Potassium Chloride	149	42
Lisinopril	Lisinopril	142	44
Meloxicam	Meloxicam	141	46
Gabapentin	Gabapentin	137	43
Levothyroxine Sodium	Levothyroxine Sodium	134	37
Prednisone	Prednisone	114	56
Hydralazine Hcl	Hydralazine Hcl	111	30
Tamsulosin Hcl	Tamsulosin Hcl	109	34
Metformin Hcl Er	Metformin Hcl	97	30
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	96	30
Rosuvastatin Calcium	Rosuvastatin Calcium	92	30
Eliquis	Apixaban	85	22
Diclofenac Sodium	Diclofenac Sodium	84	21
Ibuprofen	Ibuprofen	83	27
Allopurinol	Allopurinol	79	22
Hydroxyzine Hcl	Hydroxyzine Hcl	68	30
Clonidine Hcl	Clonidine Hcl	66	20
Furosemide	Furosemide	65	24
Naproxen	Naproxen	63	12
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	63	19
Fluticasone Propionate	Fluticasone Propionate	62	17
Labetalol Hcl	Labetalol Hcl	58	12
Metoprolol Tartrate	Metoprolol Tartrate	57	16
Trazodone Hcl	Trazodone Hcl	56	15
Alprazolam	Alprazolam	55	suppressed
Valsartan	Valsartan	54	12
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	53	12
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	53	16
Ozempic	Semaglutide	53	suppressed
Baclofen	Baclofen	52	11
Finasteride	Finasteride	52	11
Pantoprazole Sodium	Pantoprazole Sodium	50	14
Clopidogrel	Clopidogrel Bisulfate	49	14
Montelukast Sodium	Montelukast Sodium	49	17
Sertraline Hcl	Sertraline Hcl	49	13
Colchicine	Colchicine	47	18
Mirtazapine	Mirtazapine	47	14
Januvia	Sitagliptin Phosphate	45	12
Acetaminophen-Codeine	Acetaminophen With Codeine	44	12
Doxazosin Mesylate	Doxazosin Mesylate	44	13
Humulin 70/30 Kwikpen	Insulin Nph Hum/Reg Insulin Hm	39	suppressed
Azelastine Hcl	Azelastine Hcl	38	17
Lorazepam	Lorazepam	37	11
Carvedilol	Carvedilol	35	12
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	35	12
Nifedipine Er	Nifedipine	34	12
Triamcinolone Acetonide	Triamcinolone Acetonide	34	19
Zolpidem Tartrate	Zolpidem Tartrate	34	suppressed
Azithromycin	Azithromycin	33	25
Quetiapine Fumarate	Quetiapine Fumarate	33	suppressed
Spironolactone	Spironolactone	33	11
Vitamin D2	Ergocalciferol (Vitamin D2)	32	suppressed
Bumetanide	Bumetanide	31	suppressed
Nebivolol Hcl	Nebivolol Hcl	31	suppressed
Farxiga	Dapagliflozin Propanediol	30	suppressed
Meclizine Hcl	Meclizine Hcl	30	12
Methocarbamol	Methocarbamol	30	20
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	30	23
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	29	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	28	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	27	11
Levetiracetam	Levetiracetam	27	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	27	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	26	suppressed
Breo Ellipta	Fluticasone/Vilanterol	26	suppressed
Famotidine	Famotidine	26	12
Humalog Mix 75-25 Kwikpen	Insulin Lispro Protamin/Lispro	26	suppressed
Propranolol Hcl Er	Propranolol Hcl	26	suppressed
Glipizide Er	Glipizide	24	suppressed
Jardiance	Empagliflozin	24	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	24	suppressed
Diazepam	Diazepam	23	suppressed
Duloxetine Hcl	Duloxetine Hcl	23	suppressed
Xarelto	Rivaroxaban	23	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	22	suppressed
Pregabalin	Pregabalin	22	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	21	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	20	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	19	suppressed
Spiriva Handihaler	Tiotropium Bromide	19	suppressed
Glipizide	Glipizide	18	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	17	13
Fluconazole	Fluconazole	17	suppressed
Indomethacin	Indomethacin	17	suppressed
Irbesartan	Irbesartan	17	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	17	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	17	suppressed
Risperidone	Risperidone	17	suppressed
Humira	Adalimumab	15	suppressed
Methimazole	Methimazole	15	suppressed
Spiriva Respimat	Tiotropium Bromide	15	suppressed
Symbicort	Budesonide/Formoterol Fumarate	15	suppressed
Cilostazol	Cilostazol	14	suppressed
Acyclovir	Acyclovir	13	suppressed
Bupropion Xl	Bupropion Hcl	13	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	13	suppressed
Divalproex Sodium	Divalproex Sodium	13	suppressed
Novolin 70-30	Insulin Nph Hum/Reg Insulin Hm	13	suppressed
Temazepam	Temazepam	13	suppressed
Atenolol	Atenolol	12	suppressed
Chlorthalidone	Chlorthalidone	12	suppressed
Clonazepam	Clonazepam	12	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	12	suppressed
Codeine Sulfate	Codeine Sulfate	12	suppressed
Ezetimibe	Ezetimibe	12	suppressed
Glimepiride	Glimepiride	12	suppressed
Humulin 70-30	Insulin Nph Hum/Reg Insulin Hm	12	suppressed
Ketoconazole	Ketoconazole	12	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Methylprednisolone	Methylprednisolone	12	12
Olmesartan-Amlodipine-Hctz	Olmesartan/Amlodipin/Hcthiazid	12	suppressed
Simvastatin	Simvastatin	12	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	12	suppressed
Amoxicillin	Amoxicillin	11	11
Dutasteride	Dutasteride	11	suppressed
Humalog	Insulin Lispro	11	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	11	11
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error